Table 4.

Measures Used in the Randomized Trial

Variables	Measures	Baseline	1-Month	6-Month
Demographics	Age, education, income, race, ethnicity, marital status, employment	X
Family/Medical History	Familial mutation, family cancer history, number of children	X
Knowledge	10-items about BRCA knowledge [34, 61]	X	X	X
Perceived Risks	Perceived risk of BRCA mutation and colon, prostate, lung, pancreatic and breast cancer	X
Attitudes	Adapted version of the Multidimensional Measure of Informed Choice [43, 44, 62]	X
Decisional Conflict	16-item Decisional Conflict Scale [63]	X		X
Help/Harm of Genetic Testing	11-items asking ways that BRCA1/2 testing could help or harm participant (e.g., “Undergoing BRCA1/2 gene testing may make me anxious or worried.”); Adapted from Bancroft et al. [64]	X	X	X
Reasons for not pursuing testing	8-items assessing reasons for not pursuing testing (e.g. “Did not know testing was an option”)	X	X	X
Genetic Counseling and Testing	Assess genetic counseling/testing/test result. Assess counseling/testing discussions with physician	X	X	X
Testing Decision Satisfaction	Satisfaction with Decision Scale [65, 66]			X
Distress	Cancer distress: 15-item Impact of Event Scale [67]; Genetic testing distress: 21-item MICRA [68]	X		X
Stress	4-item Perceived Stress Scale [69]	X		X
Cancer Worry	4-items adapted from Lerman’s Cancer Worry Scale [70]	X		X
Depression/Anxiety	PROMIS Depression and Anxiety Scales [71]			X
Global Health	PROMIS Global Health Scale [72]	X
Risk Management	Self-report of ever/last use of cancer screening tests; Assess if discussed management options with physician and physician recommendations	X		X
WI Use/Process	WI Log-in data; Perceptions of how informative and helpful WI is, perception of WI quality.		X